Investor RelationsCorporate Profile
Edgewise Therapeutics is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. Guided by our approach to targeting the muscle as an organ, we have combined our foundational expertise in muscle biology and small molecule drug discovery to build our proprietary, muscle-focused platform. The entire team at Edgewise is dedicated to our mission: changing the lives of patients and families affected by serious muscle diseases.